Mizuho Maintains Buy on Tenet Healthcare, Raises Price Target to $94
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes maintains a Buy rating on Tenet Healthcare (NYSE:THC) and raises the price target from $81 to $94.
July 11, 2023 | 11:24 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho maintains a Buy rating on Tenet Healthcare and raises the price target from $81 to $94. This could potentially lead to an increase in the stock's price.
The raised price target by Mizuho indicates a positive outlook for Tenet Healthcare. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100